Approval · Notice of Compliance 9639 · 2008
ADVATE: Notice of Compliance 9639
Issued June 25, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9639
- Date
- June 25, 2008
- Company
- Baxter Healthcare CorporationDeerfield, Illinois, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New 2000 iu presentation
- Therapeutic class
- Coagulant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ADVATE | 02313111 | Dormant |
Medicinal ingredients
- ANTIHEMOPHILIC FACTOR (RECOMBINANT) 2,000 UNIT per VIAL